Other Molecules

Akari has an ongoing discovery and early development program involving several additional tick-derived anti-inflammatory proteins. This pipeline includes a range of new and engineered proteins, including compounds only binding LTB4, histamine, serotonin and tissue targeting compounds, including an engineered version of Coversin designed to target the neuromuscular junction (NMJ).